A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

NCT02562508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

979

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia
Cervical Cancer
Vaginal Intraepithelial Neoplasia
Vulvar Intraepithelial Neoplasia
Persistent Infection

Interventions

PROCEDURE: 3 doses of HPV 16/18 bivalent vaccine
PROCEDURE: 2 doses of HPV 16/18 bivalent vaccine

Sponsor

Jun Zhang

Collaborators

[object Object]
[object Object]